COMMUNIQUÉS West-GlobeNewswire

Le KFSHRC impose son leadership en matière de veille dans les soins de santé pour le diagnostic et les soins aux patients
19/10/2024
RIYAD, Arabie Saoudite, 19 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) contribue à l’innovation mondiale en matière de soins de santé, en tirant parti de l’ [...]
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
19/10/2024
SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today [...]
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
19/10/2024
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ) is a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified [...]
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
19/10/2024
FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc . (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that [...]
Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients with Diabetic Macular Edema
18/10/2024
88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual and anatomic improvements achieved in the first 96 weeks, in this extension study of the Phase 3 PHOTON [...]
Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
18/10/2024
The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic macular edema (DME) treated with Vabysmo who identify as African American, Black, Hispanic and [...]
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/10/2024
DURHAM, N.C., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on October 16, 2024, the Compensation Committee of Chimerix’s Board of Directors granted an inducement award to a new employee [...]
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
18/10/2024
Châtillon, France, October 18, 2024 DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical [...]
DBV Technologies participera au prochain congrès de l'ACAAI 2024
18/10/2024
Châtillon, France, le 18 octobre (22 :30 CEST) 2024 DBV Technologies participera au prochain congrès de l'ACAAI 2024 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), société [...]
Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting
18/10/2024
AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40 th Annual Meeting of the Orthopedic Trauma Association (OTA) in [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/10/2024
NOVATO, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]
Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
18/10/2024
SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced [...]
Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept
18/10/2024
Webinar to be held on Tuesday, October 22, at 8:00 a.m. ET CAMBRIDGE, Mass., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will [...]
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
18/10/2024
CALGARY, Alberta, Oct. 18, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing [...]
American Shared Hospital Services Announces Key Management Appointments
18/10/2024
Hires Gary Delanois, Seasoned Radiation Oncology Services Executive, as Chief Operating Officer Promotes Ranjit Pradhan to Senior Vice President of Sales and Marketing SAN FRANCISCO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- [...]
“A meaningful first step in acknowledging decades of harm”: Lung Health Foundation Applauds Landmark $32.5 Billion Legal Settlement Against Tobacco Companies
18/10/2024
TORONTO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF), Canada’s premier resource on lung health research, education, and advocacy for all Canadians, is breathing a sigh of relief. On October 17, [...]
CVRx announces new CPT® Category I codes for Barostim
18/10/2024
MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc . (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT® Editorial Panel has [...]
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
18/10/2024
New reimbursement code follows recent favorable Medicare coverage decision, expanding access to HeartFlow’s Plaque Analysis to help physicians provide personalized treatment plans MOUNTAIN VIEW, Calif., Oct. 18, 2024 ( [...]
RAMSAY SANTE :Annual results at the end of June 2024
18/10/2024
PRESS RELEASE Paris, 18 th October 2024 Annual results at the end of June 2024 As a mission-driven company, Ramsay Santé, thanks to its employees and medical community, is committed to expanding its pioneering role in [...]

Pages